A 58-year-old businessman walks into a clinic for a routine health check. He feels fine. No pain, no urinary trouble, nothing ...

Theranostics combine PSMA imaging with targeted radiation therapy to help locate and treat advanced prostate cancer using the ...

For the hundreds of thousands of men who undergo radical prostatectomy each year, one question looms over every postoperative ...

Approximately 1 in 8 men will be diagnosed with prostate cancer during their lifetime often occurring later in life.

A tracer originally designed to hunt prostate cancer is proving to be an unexpected ally in one of the world’s deadliest ...

A case report led by UCLA Health researchers highlights the importance of a multidisciplinary, evidence-based approach to ...

Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver ...

India has 0.3 PET-CT scanners per million population, way below the World Health Organization standard of 2 and the American ...

Genomic testing in high-risk prostate cancer remains underutilized nationally, driven by fragmented ordering and interpretive ...

Get latest articles and stories on Business at LatestLY. Ahmedabad (Gujarat) [India], September 29: Cancer treatment is ...

There is a moment in a prostate cancer consultation when I sometimes wish I could slow time down. The patient has already been through the blood test, the scan and ...

Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians ...